Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- SOGP +26.7%, MNSO +8.8%, SPCE +7.8%, FDS +5.6%, TOYO +3.6%, MKC +3.6%, PRGS +2.2%, BITF +1.6%, CHA +1.1%
Other news:
- APLS +140.4% (Apellis Pharmaceuticals to be acquired by Biogen (BIIB) for $41.00/share in cash at closing)
- CNTA +48.6% (Centessa Pharmaceuticals to be acquired by Eli Lilly (LLY) for $38/share in cash plus CVRs worth up to $9/share) SOGP +25.7% (announces special cash dividend)
- SRRK +12.6% (resubmitted the BLA for apitegromab for the treatment of children and adults with SMA to the FDA)
- AGIO +9.9% (moves mitapivat toward potential accelerated approval in sickle cell disease)
- FDS +5.6% (strategic partnership with Finster AI to power new AI banking platform)
- NBIS +3.6% (to build 310 MW AI data center in Finland, expands capacity pipeline)
- USAU +3.1% (delivers robust feasibility study for CK Gold Project highlighting attractive economics and detailing relative low development risk)
- RKLB +2.4% (receives regulatory approval to acquire Mynaric)
- GLPG +2.4% (Galapagos NV and Gilead (GILD) enter collaboration to advance T cell engager program)
- TNXP +2.2% (reports presentation of Phase 1 data and outlines planned adaptive Phase 2 field study of TNX-4800 for the prevention of Lyme Disease, at the World Vaccine Congress Washington 2026)
- RCAT +2.1% (discloses Share Purchase Agreement details with respect to the acquisition of all the shares in the capital of Quaze Technologies)
- OCS +2% (receives EMA PRIME designation for Privosegtor in optic neuritis)
- CGAU +1.9% (COO to depart)
- SNY +1.9% (receives EU approval for Rezurock in chronic graft-versus-host disease)
- AXP +1.5% (named official payments partner of the NFL)
- ARRY +1.2% (opening of the new headquarters of APA Solar)
- RTX +1% (awarded a $3.8 bln modification to Navy contract; also awarded a $125 mln U.S. Transportation Command contract)
- LLY +1% (Centessa Pharmaceuticals to be acquired by Eli Lilly (LLY) for $38/share in cash plus CVRs worth up to $9/share)